Abstract:A look at the day ahead in markets from Alun John

U.S. payrolls data day is dawning shortly and set to tell us whether markets should be more worried about inflation or a recession.
As Rabobank notes — Will a weak print provide more ‘pivot-fuel’ for a market already so drunk on it that it wont heed the Fed saying “WRONG!” over and over – as they just did yet again yesterday? Conversely, will a strong payrolls number sober the market up?
If markets decide good jobs news is also good news for stocks, expect the bouncers at the Fed to shout even louder.
A Reuters survey of economists expects U.S. non-farm payrolls to have increased by 250,000 jobs last month after rising by 372,000 in June. But signs from other claims and related data warns of a poor number.
The jobs data will likely outshine most morning news in Europe, though Allianz<alvg.de and=“” the=“” london=“” stock=“” exchange=“” group=“” are=“” both=“” due=“” to=“” report=“” earnings.=“”
Investors have had a night‘s sleep to see if they’re happy with their response to the Bank of England raising rates by 50bps to 1.75%, the biggest increase in 27 years – and warning of a long drawn out recession.
Two-year gilt yields fell, future hikes were priced out and cuts priced in, while the 10-year yield slipped 3bps to 1.88%.
Sterling lost ground on the euro, though clawed back its initial losses against the dollar in U.S. trading.
Shares rose in Asia this morning, particuarly in Taiwan, as markets decided China firing missiles near the island after Nancy Pelosis visit was less worrisome than it could have been.
Key developments that could influence markets on Friday:
Economic data: US non-farm payrolls July, Canadian July jobs data, German June industrial output, UK Halifax housing data July
Europe earnings: Deutsche Post, London Stock Exchange, Rheinmetall, Allianz, WPP, Hargreaves Landsdown


When smart traders look at a new broker, the first and most important question is always about regulation. Before investing, understanding a broker's legal status and what protections they offer is absolutely essential. BDSWISS says it is a regulated trading partner globally. However, when we look closely at its regulatory setup, company structure and real-world track record, we find a big and worrying gap. The reality is much more complicated and concerning than what its marketing shows. This investigation will break down the key areas that every potential client needs to understand: its main offshore license, a history of serious regulatory warnings, a confusing company structure, and a huge number of user complaints that show a major problem. This analysis is designed to confirm your concerns and give you the evidence needed to avoid a potentially expensive mistake.

This TenX Prime review examines the broker through the lens of regulatory status and user complaints recorded on WikiFX.

This Exclusive Markets review provides a detailed analysis of the broker’s regulatory framework, licensing structure, WikiScore rating, and user feedback based on information available on WikiFX.

You're asking 'Is BDSWISS Legit?' or maybe even 'Is BDSWISS a scam?' and you need clear, factual answers. The worry behind that question makes sense. When your capital is at risk, trust isn't just a nice extra feature; it's absolutely essential. This article promises a direct, fact-based investigation into whether BDSWISS is legitimate. We will cut through the marketing hype and analyze the broker based on three key areas: its regulatory status, independent expert ratings, and most importantly, a large number of real, recent user complaints. Our analysis is based on solid data to give you the clarity you need. We understand how serious your concern is, and our goal is to present the facts without exaggeration, allowing you to make an informed decision to protect your investments.